Lausanne-based Adaptyv raises €34.35 million Series A to build the automated lab for agentic biology
Source ↗
👁 1
💬 0
Adaptyv Bio, the Lausanne-based BioTech startup building an automated wet lab for AI-driven protein design, has raised a €34.35 million ($40 million) Series A round.
The round was led by Highland Europe, with existing investors Ace Ventures, ByFounders, and Y Combinator doubling down. Ace Ventures led the company’s €6.8 million ($8 million) Seed round in late 2024.
“AI has made it easy to design proteins. Many teams can now create thousands of candidate molecules for a target in an
The round was led by Highland Europe, with existing investors Ace Ventures, ByFounders, and Y Combinator doubling down. Ace Ventures led the company’s €6.8 million ($8 million) Seed round in late 2024.
“AI has made it easy to design proteins. Many teams can now create thousands of candidate molecules for a target in an
Comments (0)